Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Alan Meds vs Wellorithm

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.7

Alan Meds

Best for budget-conscious shoppers
★★★3.9

Starting at $99/mo

CompoundedSemaglutideTirzepatideOral Format
Visit Alan Meds
7.2

Wellorithm

Best for compounded GLP-1 access with oral tablet options across 49 states
★★★3.6
Compounded SemaglutideCompounded TirzepatideOral Dissolving TabletsInjectable
Visit Wellorithm

Side-by-Side Comparison

FeatureAlan MedsWellorithm
Overall Score7.7/107.2/10
Starting Price$99/mo
Editorial Rating3.9 ★ /53.6 ★ /5
Features5 features4 features
States Available4649
Compounded✓ Yes
Brand Name
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

Alan Meds

Pros

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access
  • Multiple administration formats

Cons

  • Limited public information on program details

Wellorithm

Pros

  • Four compounded GLP-1 formats: semaglutide injectable, semaglutide oral dissolving tablets, tirzepatide injectable, tirzepatide oral dissolving tablets
  • Available in 49 states — broader coverage than most compounded GLP-1 telehealth providers
  • Board-certified obesity specialists with virtual consultations
  • 2-minute quiz onboarding — fast async approval path
  • 24/7 support with dedicated phone line
  • Katalys RevOffers tracking pixel detected — affiliate program active

Cons

  • Not available in Louisiana
  • Pricing not publicly disclosed on their website — requires completing the intake quiz
  • No visible LegitScript certification or PCAB accreditation
  • Compounded medications have not been reviewed or approved by the FDA (stated on their site)

Our Verdict

Winner: Alan MedsScore: 7.7/10

Alan Meds edges out Wellorithm with a higher overall score of 7.7/10 and is particularly strong for budget-conscious shoppers. Wellorithm remains a solid alternative, especially if you're looking for compounded GLP-1 access with oral tablet options across 49 states.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.